Be part of the knowledge.

ReachMD is even better when
you join the community!
Registration is free and easy.

Register Now

Then and Now: Expert Insights on Understanding the Women’s Health Initiative Hormone Therapy Trials

This educational program is intended to educate healthcare practitioners who treat postmenopausal women about the accurate interpretation of data f...

Available credits: 0.75

Time to complete: 45 minutes


Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    This educational program is intended to educate healthcare practitioners who treat postmenopausal women about the accurate interpretation of data from the Women’s Health Initiative hormone therapy clinical trials, while increasing awareness that a significant amount of data exist to support the appropriate use of hormone therapy as an option for treating postmenopausal symptoms in the appropriate women.

  • Learning Objectives

    Upon completion of this education program, participants will be able to:

    • Re-evaluate their knowledge of WHI HT trials, including initial and follow-up results for Estrogen Therapy (ET) and Estrogen + Progestin Therapy (EPT)
    • Assess the benefits and risks of current and newer HT options to identify individualized treatment
    • Recognize key gaps in current clinical guidelines and the interpretation of WHI data
    • Be able to communicate on the appropriate use of HT for postmenopausal women
  • Target Audience

    The target audience for this activity includes primary care physicians, physician assistants, nurse practitioners, obstetricians/gynecologists, and other specialists who manage the health of postmenopausal women (e.g., endocrinologists, psychiatrists, orthopedists, cardiologists).

  • Disclosure of Conflicts of Interest

    JoAnn V. Pinkerton, MD
    Medical Director of MidLife Health Center
    Professor of Obstetrics and Gynecology and Vice Chair of Academic Affairs
    University of Virginia, Charlottesville.

    Andrew M Kaunitz, MD, FACOG
    Medical Director, UF Health Women’s Specialists - Emerson
    Associate Chair, Department of Obstetrics and Gynecology
    Division of General Obstetrics and Gynecology
    University of Florida, Jacksonville

    André B. Lalonde, MD
    Professor of Obstetrics and Gynaecology
    University of Ottawa and McGill University
    Professor of Health Administration
    University of Ottawa
    Past executive vice-president of the Society of Obstetricians and Gynaecologists of Canada (SOGC)

    Dr. JoAnn V. Pinkerton

    • Consultant/Independent Contractor: Pfizer ( Fees to UVA)
    • Grant/Research Support: PI Multicenter Clinical Trial ( fees to UVA) Therapeutic MD
    • Honoraria: none

     Dr. Andrew M. Kaunitz

    • Grant/Research Support: Bayer, Therapeutics MD
    • Honoraria: Bayer, Allergan, Merck, Pfizer
    • Royalties: UpToDate

     Dr. André B. Lalonde has nothing to disclose.

    The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

    • Andrea Funk has nothing to disclose
    • Amanda Glazar, PhD has nothing to disclose
    • Lynn Heywood-McLean has nothing to disclose
  • Accreditation and Credit Designation Statements

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Clinical and Patient Educators Association (CPEA) and Diversified Health Communications. CPEA is accredited by the ACCME to provide continuing medical education for physicians.

    CPEA designates this enduring materials for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider(s)/Educational Partner(s)

    This activity is jointly provided by Clinical and Patient Educators Association (CPEA) and CME Solutions International (formerly Diversified Health Communications).

  • Commercial Support

    This activity is supported by an independent educational grant from Pfizer.

  • Instructions

    There is no fee for this activity. Upon completion of reivew of the content, please complete the posttest with a passing score of at least 75% as well as complete the evaluation and application for credit.

  • Terms of Use

    This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Neither Clinical & Patient Educators Association nor CME Solutions International (formerly Diversified Health Communications) recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Clinical & Patient Educators Association and Diversified Health Communications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Clinical & Patient Educators Association & CME Solutions International (formerly Diversified Health Communications). This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of ReachMD you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site. Reproduction of this material is not permitted without written permission from the copyright owner. 

  • System Requirements

    Our site requires a computer, tablet or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/cable). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Internet Explorer, Microsoft Edge, Chrome, Firefox or Safari. Users accustomed to IE8, IE9 IE10 are advised to update their browsers for the best experience."

Facebook Comments

You must be in to display playlists.

Get a Dose of ReachMD in Your Inbox
and Practice Smarter Medicine

Stay current with the best in medical education.